Quest Partners LLC Eye Point Pharmaceuticals, Inc. Transaction History
Quest Partners LLC
- $1.12 Trillion
- Q3 2024
A detailed history of Quest Partners LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 73 shares of EYPT stock, worth $529. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73
Previous 8,905
99.18%
Holding current value
$529
Previous $77.5 Million
99.25%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding EYPT
# of Institutions
150Shares Held
58MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$60.4 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$37.5 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$29.1 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$27.5 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$27.3 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $247M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...